Entry Detail



General Information

Database ID:exR0090624
RNA Name:hsa-miR-143-3p
RNA Type:miRNA
Chromosome:chr5
Starnd:+
Coordinate:
Start Site(bp):149428978End Site(bp):149428998
External Links:hsa-miR-143-3p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ACVR1B
chr12
51951699
51997078
+
BTF3L4
chr1
52056199
52090716
+
BTG2
chr1
203305491
203309602
+
CAPZB
chr1
19338775
19485539
-
CDK6
chr7
92604921
92836594
-
CELSR2
chr1
109249539
109275751
+
CIT
chr12
119685791
119877320
-
DEGS1
chr1
224175756
224193441
+
DYRK1B
chr19
39825350
39834201
-
EFNA3
chr1
155078837
155087538
+
FOSL2
chr2
28392448
28417317
+
IGFBP5
chr2
216672105
216695549
-
KRIT1
chr7
92198969
92246166
-
MAP3K3
chr17
63622415
63696303
+
NES
chr1
156668763
156677407
-
PACS1
chr11
66070272
66244744
+
PATL1
chr11
59636716
59669037
-
PNKD
chr2
218270392
218346793
+
RFWD3
chr16
74621399
74666877
-
SLC7A11
chr4
138164097
138242349
-
SON
chr21
33543038
33577481
+
STARD4
chr5
111496033
111512590
-
STMN3
chr20
63639705
63657682
-
TATDN2
chr3
10248023
10281218
+
TFPI
chr2
187464230
187565760
-
TIGD5
chr8
143597831
143603224
+
VPS37C
chr11
61130257
61161615
-
WSB1
chr17
27294076
27315926
+
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0001247
chr22
46125304
46136418
+
hsa_circ_0000711
chr16
68155889
68160513
+
hsa_circ_0000431
chr12
102301963
102308010
+
hsa_circ_0001168
chr20
47691321
47707559
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC009022.1
chr16
69976297
70065948
-
AC091564.7
chr11
6610883
6616594
-
AC245884.8
chr19
54438665
54439544
-
DHRS4-AS1
chr14
23938219
24052555
-
LINC00667
chr18
5237826
5290608
+
LZTS1-AS1
chr8
20275773
20290458
+
MALAT1
chr11
65497688
65506516
+
MCM3AP-AS1
chr21
46229196
46259390
+
OIP5-AS1
chr15
41283990
41309737
+
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.